Skip to main content

CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator



CD146 is highly expressed in various malignant tumors and contributes to their malignancy phenotype, which involves metastatic and tumorigenic activity. However, studies on the expression and function of CD146 in brain tumors are limited.


We over-expressed or knocked-down CD146 in both conventionally cultured glioma cells and tumor spheres (TS). The distribution of glioma cells and their stem cells in different cell cycle phases was analyzed by flow cytometry using the stem cell marker CD133 and the glial precursor marker A2B5. CD146 expression was immunohistochemically examined in glioma tissues.


The majority of glioma stem cells (GSCs) expressing CD133 were also CD146-positive. CD146 knockdown in GSCs significantly compromised cell growth. Cell cycle analysis revealed that most of the CD146 and CD133 double-positive cells were in the G2/M phase. Ectopic expression of CD146 in parental glioma cells resulted in cell cycle arrest of most differentiated cells in G0/G1 phase. In contrast, ectopic expression of CD146 in GSCs resulted in an increase in the number of CD133-positive cells in the G2/M phase. Furthermore, CD146 knockdown reduced the number of CD133-positive cells in the G2/M phase, which was consistent with effects of cell growth inhibition. Immunohistochemical analysis revealed that CD146 expression was significantly upregulated in World Health Organization (WHO) Grade III and IV glioma and positively correlated with CD133 expression.


CD146 is mainly expressed in dividing GSCs and may be a potential target for eradicating glioma stem cells.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5


  1. DeAngelis LM, Gutin PH, Leibel SA, Posner JB (2002) Intracranial tumors: diagnosis and treatment. Martin Dunitz, London, pp 367–394

    Google Scholar 

  2. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401

    Article  CAS  Google Scholar 

  3. Singh SK, Clarke ID, Hide T, Dirks PB (2004) Cancer stem cells in nervous system tumors. Oncogene 23:7267–7273

    Article  CAS  PubMed  Google Scholar 

  4. Nonaka M, Yawata T, Takemura M et al (2015) Elevated cell invasion in a tumor sphere culture of RSV-M mouse glioma cells. Neurol Med Chir (Tokyo) 55:60–70

    Article  Google Scholar 

  5. Johnson JP, Rothbächer U, Sers C (1993) The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family. Melanoma Res 3:337–340

    Article  CAS  PubMed  Google Scholar 

  6. Shih IM (1999) The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189:4–11

    Article  CAS  PubMed  Google Scholar 

  7. Bardin N, Francès V, Lesaule G et al (1996) Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 218:210–216

    Article  CAS  PubMed  Google Scholar 

  8. Wang Z, Yan X (2013) CD146, a multi-functional molecule beyond adhesion. Cancer Lett 330:150–162

    Article  CAS  PubMed  Google Scholar 

  9. Shih I, Wang T, Wu T et al (1998) Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J Cell Sci 111:2655–2664

    CAS  PubMed  Google Scholar 

  10. Covas DT, Panepucci RA, Fontes AM et al (2008) Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascularcells and fibroblasts. Exp Hematol 36:642–654

    Article  CAS  PubMed  Google Scholar 

  11. Russell KC, Phinney DG, Lacey MR et al (2010) In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28:788–798

    Article  CAS  PubMed  Google Scholar 

  12. Johnson JP, Rummel MM, Rothbacher U, Sers C (1996) MUC18: a cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. Curr Top Microbiol Immunol 213:95–105

    CAS  PubMed  Google Scholar 

  13. Wu GJ (2012) Dual roles of METCAM in the progression of different cancers. J Oncol 2012:853797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zeng P, Li H, Lu PH et al (2017) Prognostic value of CD146 in solid tumor: a systematic review and meta-analysis. Sci Rep 7:4223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824–828

    Article  CAS  PubMed  Google Scholar 

  17. Wang R, Chadalavada K, Wilshire J et al (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829–833

    Article  CAS  PubMed  Google Scholar 

  18. Soda Y, Marumoto T, Friedmann-Morvinski D et al (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108:4274–4280

    Article  PubMed  Google Scholar 

  19. Sorrentino A, Ferracin M, Castelli G et al (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 36:1035–1046

    Article  CAS  Google Scholar 

  20. Jaksch M, Múnera J, Bajpai R et al (2008) Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 68:7882–7886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jiang T, Zhuang J, Duan H et al (2012) CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood 120:2330–2339

    Article  CAS  PubMed  Google Scholar 

  22. Li G, Kalabis J, Xu X et al (2003) Reciprocal regulation of MelCAM and AKT in human melanoma. Oncogene 22:6891–6899

    Article  CAS  PubMed  Google Scholar 

  23. Xu C, Wu X, Zhu J (2013) VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2. Sci World J 2013:417413

    Google Scholar 

  24. Sers C, Kirsch K, Rothbächer U et al (1993) Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci USA 90:8514–8518

    Article  CAS  PubMed  Google Scholar 

  25. Heimberger AB, McGary EC, Suki D et al (2005) Loss of the AP-2α transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11:267–272

    Article  CAS  PubMed  Google Scholar 

Download references


We thank Motoki Kondo and Sayo Kataoka (Science Research Center, Kochi University, Kochi, Japan) for technical assistance.


This study was funded by Grants-in-Aid (Nos. 25462267, 17K10867, 17H06920 and 18K08969) from the Ministry of Education, Science, Sports and Culture, Japan.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Toshio Yawata.

Ethics declarations

Conflict of interest

All authors declare no competing financial interests.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 207 kb)

Supplementary file2 (DOCX 35 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yawata, T., Higashi, Y., Kawanishi, Y. et al. CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator. J Neurooncol 144, 21–32 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • CD146
  • Glioma stem cell
  • Glioblastoma
  • Cell cycle
  • Adhesion molecule